Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis

Hypertension Research

Volumn 34, Issue 2, 2011, Pages 193-201

  Aritomi, Shizuka ^a   Wagatsuma, Hirotaka ^a   Numata, Tomohiro ^b   Uriu, Yoshitsugu ^b   Nogi, Yasuko ^a   Mitsui, Akira ^a   Konda, Tomoyuki ^a   Mori, Yasuo ^b   Yoshimura, Michihiro ^c  

^a Kawasaki 220   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

adrenal gland; aldosterone; angiotensin II; calcium channel blockers; N type calcium channels

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; CALCIUM; CALCIUM CHANNEL N TYPE; CILNIDIPINE; CORTICOSTEROID; EFONIDIPINE; HYDROCORTISONE; MESSENGER RNA; NIFEDIPINE; OMEGA CONOTOXIN; STEROID 11BETA MONOOXYGENASE;

ADRENAL CORTEX CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; GENE EXPRESSION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MEMBRANE POTENTIAL; PATCH CLAMP; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS; WESTERN BLOTTING;

ADRENAL CORTEX; ADRENAL CORTEX HORMONES; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; BARIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CALCIUM SIGNALING; CELL LINE; DIHYDROPYRIDINES; HUMANS; OMEGA-CONOTOXINS; STEROID 11-BETA-HYDROXYLASE;

EID: 79751490939     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.191     Document Type: Article

References (36)

1. Goodfriend TL. Aldosterone-a hormone of cardiovascular adaptation and maladaptation. J Clin Hypertens (Greenwich) 2006; 8: 133-139.
2. Brown NJ. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 2005; 14: 235-241. (Pubitemid 40685635)
3. Bianchi S, Bigazzi R, Campese VM. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int 2006; 70: 2116-2123. (Pubitemid 44871374)
4. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y, Nakao K. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103: 72-77. (Pubitemid 32050438)
5. Yamamoto N, Yasue H, Mizuno Y, Yoshimura M, Fujii H, Nakayama M, Harada E, Nakamura S, Ito T, Ogawa H. Aldosterone is produced from the ventricles of patients with essential hypertension. Hypertension 2002; 39: 958-962. (Pubitemid 34547793)
6. Mizuno Y, Yasue H, Yoshimura M, Harada E, Fujii H, Nakamura S, Yamamoto N, Ogawa H, Nakao K. Adrenocorticotropic hormone is produced in the ventricle of patients with essential hypertension. J Hypertens 2005; 23: 411-416. (Pubitemid 40279645)
7. Spä t A, Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 2004; 84: 489-539.
8. Natke Jr E, Kabela E. Electrical responses in cat adrenal cortex: possible relation to aldosterone secretion. Am J Physiol 1979; 237: E158-E162. (Pubitemid 9240777)
9. Aguilera G, Catt KJ. Participation of voltage-dependent calcium channels in the regulation of adrenal glomerulosa function by angiotensin II and potassium. Endocrinology 1986; 118: 112-118. (Pubitemid 16186421)
10. Rossier MF, Burnay MM, Vallotton MB, Capponi AM. Distinct functions of T- and L-type calcium channels during activation of bovine adrenal glomerulosa cells. Endocrinology 1996; 137: 4817-4826. (Pubitemid 26403323)
11. Takahara A. Cilnidipine: a new generation ca channel blocker with inhibitory action on sympathetic neurotransmitter release. Cardiovasc Ther 2009; 27: 124-139.
12. Morad M, Davies NW, Kaplan JH, Lux HD. Inactivation and block of calcium channels by photo-released Ca2+ in dorsal root ganglion neurons. Science 1988; 241: 842-844.
13. Patil PG, Brody DL, Yue DT. Preferential closed-state inactivation of neuronal calcium channels. Neuron 1998; 20: 1027-1038. (Pubitemid 28247407)
14. Dubel SJ, Starr TV, Hell J, Ahlijanian MK, Enyeart JJ, Catterall WA, Snutch TP. Molecular cloning of the a-1 subunit of an o-conotoxin-sensitive calcium channel. Proc Natl Acad Sci 1992; 89: 5058-5062.
15. Jeong SW, Wurster RD. Calcium channel currents in acutely dissociated intracardiac neurons from adult rats. J Neurophysiol 1997; 77: 1769-1778. (Pubitemid 27174973)
16. Smith PA. N-type Ca2+-channels in murine pancreatic {beta}-cells are inhibited by an exclusive coupling with somatostatin receptor subtype 1. Endocrinology 2009; 150: 741-748.
17. Wykes RC, Bauer CS, Khan SU, Weiss JL, Seward EP. Differential regulation of endogenous N- and P/Q-type Ca2+ channel inactivation by Ca2+/calmodulin impacts on their ability to support exocytosis in chromaffin cells. J Neurosci 2007; 27: 5236-5248. (Pubitemid 46741775)
18. Dunlap K, Luebke JI, Turner TJ. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci 1995; 18: 89-98.
19. Bell TJ, Thaler C, Castiglioni AJ, Helton TD, Lipscombe D. Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron 2004; 41: 127-138. (Pubitemid 38068440)
20. Khanna R, Zougman A, Stanley EF. A proteomic screen for presynaptic terminal N-type calcium channel (CaV2.2) binding partners. J Biochem Mol Biol 2007; 40: 302-314. (Pubitemid 46833837)
21. Konda T, Enomoto A, Aritomi S, Niinuma K, Koganei H, Ogawa T, Nitta K. Different effects of L/N-Type and L-Type calcium channel blockers on the reninangiotensin- aldosterone system in SHR/Izm. Am J Nephrol 2009; 30: 155-161.
22. Takahara A, Nakamura Y, Wagatsuma H, Aritomi S, Nakayama A, Satoh Y, Akie Y, Sugiyama A. Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. Br J Pharmacol 2009; 158: 1366-1374.
23. Rainey WE, Saner K, Schimmer BP. Adrenocortical cell lines. Mol Cell Endocrinol 2004; 228: 23-38. (Pubitemid 39482517)
24. Suzuki J, Otsuka F, Inagaki K, Takeda M, Ogura T, Makino H. Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 2004; 145: 639-649. (Pubitemid 38183806)
25. Siriannj R, Carr BR, Pezzi V, Rainey WE. A role for src tyrosine kinase in regulating adrenal aldosterone production. J Mol Endocrinol 2001; 26: 207-215. (Pubitemid 32514611)
26. Wakamori M, Yamazaki K, Matsunodaira H, Teramoto T, Tanaka I, Niidome T, Sawada K, Nishizawa Y, Sekiguchi N, Mori E, Mori Y, Imoto K. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel. J Biol Chem 1998; 273: 34857-34867. (Pubitemid 29028180)
27. Liu J, Li XD, Ora A, Heikkijä P, Vaheri A, Voutilainen R. cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells. J Mol Endocrinol 2004; 33: 511-522. (Pubitemid 39429573)
28. Romero DG, Plonczynski M, Vergara GR, Gomez-Sanchez EP, Gomez-Sanchez CE. Angiotensin II early regulated genes in H295R human adrenocortical cells. Physiol Genomics 2004; 19: 106-116.
29. Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. Eur J Pharmacol 2008; 584: 424-434.
30. Romero DG, Plonczynski MW, Gomez-Sanchez EP, Yanes LL, Gomez-Sanchez CE. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. Endocrinology 2006; 147: 3889-3897. (Pubitemid 44079394)
31. Rossier MF, Python CP, Capponi AM, Schlegel W, Kwan CY, Vallotton MB. Blocking Ttype calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells. Endocrinology 1993; 132: 1035-1043. (Pubitemid 23068616)
32. Lisurek M, Bernhardt R. Modulation of aldosterone and cortisol synthesis on the molecular level. Mol Cell Endocrinol 2004; 215: 149-159. (Pubitemid 38333254)
33. Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension. Hypertens Res 2007; 30: 691-697. (Pubitemid 47517102)
34. Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ohta S, Yoshii M, Minami J, Ono H, Numabe A, Matsuoka H. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. Hypertens Res 2007; 30: 621-626. (Pubitemid 47278320)
35. Bird IM, Mathis JM, Mason JI, Rainey WE. Ca(2+)-regulated expression of steroid hydroxylases in H295R human adrenocortical cells. Endocrinology 1995; 136: 5677-5684. (Pubitemid 3015470)
36. Kuji N, Minamisawa K, Yamakado M, Tochikubo O, Ishii M. Antihypertensive effect and pharmacokinetics of FRC-8653 (Cilnidipine) on hypertensive patients with renal impairment or normal renal function. Jpn Pharmacol Ther 1993; 21(Suppl 1): 193-205. (in Japanese).